** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
  1. Home
  2. »
  3. Recalls and Alerts
  4. »
  5. Public Alert No. 049/2022 – Alert on the UAE health authority warning against consumption of…

Public Alert No. 049/2022 – Alert on the UAE health authority warning against consumption of weight loss pills

,

The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the Department of Health – Abu Dhabi (DOH) has warned against the use of the Weight Rapid Loss Capsule, due to its potential to cause cancer.

The product is being -marketed as “the most effective weight loss supplement” and is being illegally sold through social media platforms like Instagram.

Result of laboratory analysis showed that the pills contain a banned substance “phenolphthalein”, which the US Food and Drug Administration has recognized as unsafe. It further contains microbial growth above the permissible limits.

Phenolphthalein has been found to be toxic to genes as it can cause damage or mutations in the DNA. Studies have also shown its potential carcinogenic risks.

Product details

The details of the products are as follows;

Product Name: Weight Rapid Loss Capsule

Product Manufacturer: Ingi Oman

Product Photo

NAFDAC implores consumers to stop the purchase and use of the product.

Members of the public in possession of the product should discontinue sale or use and submit stock to the nearest NAFDAC office.

Healthcare professionals and consumers are encouraged to report adverse events experienced with the use of the product to the nearest NAFDAC office, via pharmacovigilance@nafdac.gov.ng, E-reporting platforms available at www.nafdac.gov.ng or via the Med- safety application for download on android and IOS stores.

NAFDAC……..Customer-focused, Agency-minded!!!

Signed Management

Was this helpful?

Yes
No
Thanks for your feedback!

More Actions